Amanote Research
Register
Sign In
366. Reprogramming Mouse iPS Cells as a New Approach to Correct the Stem Cell Defect in the Mpl−/− Mouse Model
Molecular Therapy
- United States
doi 10.1016/s1525-0016(16)36938-6
Full Text
Open PDF
Abstract
Available in
full text
Categories
Molecular Medicine
Molecular Biology
Pharmacology
Medicine
Genetics
Drug Discovery
Date
May 1, 2011
Authors
Unknown
Publisher
Elsevier BV
Related search
Integrated Approach to Study Mouse Embryonic Stem Cell Proteome
Journal of Proteomics & Bioinformatics
A New Approach to Generate Tailed-Sperm and Oocytes in Vitro From the Same Mouse Embryonic Stem Cells
Cell Research
Cell Biology
Molecular Biology
Cancer Stem Cell Induction From Mouse Embryonic Stem Cells
Oncology Letters
Cancer Research
Oncology
Reprogramming the Genome to Totipotency in Mouse Embryos
Trends in Cell Biology
Cell Biology
Proteomic Analysis of Mouse Oocytes Identifies PRMT7 as a Reprogramming Factor That Replaces SOX2 in the Induction of Pluripotent Stem Cells
Journal of Proteome Research
Biochemistry
Chemistry
Myogenic Reprogramming of Bone Marrow Derived Cells in a W41Dmdmdx Deficient Mouse Model
PLoS ONE
Multidisciplinary
Inhibition of the Integrin Signal Constitutes a Mouse iPS Cell Niche
Development Growth and Differentiation
Medicine
Developmental Biology
Cell Biology
Human Gingival Mesenchymal Stem Cells (GMSCs) Pre‐treated With Vesicular Moringin Nanostructures as a New Therapeutic Approach in a Mouse Model of Spinal Cord Injury
Journal of Tissue Engineering and Regenerative Medicine
Medicine
Biomedical Engineering
Biomaterials
Autograft Microskin Combined With Adipose-Derived Stem Cell Enhances Wound Healing in a Full-Thickness Skin Defect Mouse Model
Stem Cell Research and Therapy
Genetics
Cell Biology
Molecular Biology
Biochemistry
Medicine
Molecular Medicine
